Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?The Motley Fool • 11/21/23
Recursion Pharmaceuticals: Second Half 2024 Data Readouts Are Major Inflection PointsSeeking Alpha • 11/16/23
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision OncologyGlobeNewsWire • 11/09/23
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/09/23
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to AvoidThe Motley Fool • 10/13/23
Recursion Pharmaceuticals: Leveraging AI To Decode Biology And Discover Novel TherapeuticsSeeking Alpha • 09/14/23
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall StreetThe Motley Fool • 09/12/23